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Abstract
Members of the Chlamydiales order are obligate intracellular pathogens causing acute and chronic infectious diseases. Chlamydiaceae are
established agents of community- and zoonotically acquired respiratory tract infections, and emerging pathogens among the Chlamydia-
related bacteria have been implicated in airway infections. The role of both in airway infections in Africa is underexplored. We
performed a case -control study on the prevalence of Chlamydiaceae and Chlamydia-related emerging pathogens in children with febrile
respiratory tract infections in West Africa, Ghana. Using a pan-Chlamydiales broad-range real-time PCR, we detected chlamydial DNA
in 11 (1.9%) of 572 hospitalized febrile children with respiratory tract symptoms and in 24 (4.3%) of 560 asymptomatic age-matched
controls (p 0.03). Chlamydiaceae were found to be common among both symptomatic and healthy Ghanaian children, with Chlamydia
pneumoniae being the most prevalent species. Parachlamydiaceae were detected in two children without symptoms but not in the
symptomatic group. We identiﬁed neither Chlamydia psittaci nor Simkania negevensis but a member of a new chlamydial family that
shared 90.2% sequence identity with the 16S rRNA gene of the zoonotic pathogen Chlamydia pecorum. In addition, we found a new
Chlamydia-related species that belonged to a novel family sharing 91.3% 16S rRNA sequence identity with Candidatus Syngnamydia
venezia. The prevalence and spectrum of chlamydial species differed from previous results obtained from children of other geographic
regions and our study indicates that both, Chlamydiaceae and Chlamydia-related bacteria, are not clearly linked to clinical symptoms in
Ghanaian children.
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Introduction
Members of the order Chlamydiales are strictly intracellular
pathogens featuring a biphasic developmental cycle. Chlamy-
diaceae are responsible for many acute and chronic diseases in
humans and animals. In the context of respiratory tract in-
fections, Chlamydia pneumoniae and Chlamydia psittaci are
established pathogens causing community- and zoonotically
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acquired pneumonia, respectively [1]. Chlamydia trachomatis is
a major cause of sexually transmitted diseases and can cause
pneumonia in neonates if transmitted during birth [2]. Chla-
mydia-related bacteria are emerging pathogens; amongst
others, Protochlamydia, Waddlia and Simkania have been
considered to be responsible for respiratory tract infections
in humans, the latter especially in children [3–5].
The prevalence of respiratory tract infections associated with
C. pneumoniae has been reported to range from 0 to 44.2%,
depending on the population, the age distribution, the geographic
region studied and the diagnostic methods used [6]. In recent
studies, a decrease in respiratory tract infections caused by
C. pneumoniae was reported in the setting of industrial countries
[7,8].
Little is known about the role of chlamydiae in respiratory tract
infections in Africa. So far, only C. pneumoniae and C. trachomatis
have been considered in studies on aetiologic agents of airway
infections in African patients. Among refugees with respiratory
infections who originated predominantly from Somalia and Sudan
and who lived in Kenyan and Djiboutian refugee camps, 3.8% and
5.2% were found to be positive for C. pneumoniae, respectively
[9,10]. In South Africa in the 1980s, C. pneumoniaewas associated
with 20.7% of community-acquired pneumonia in adults [11]. A
study conducted in Alexandria and neighbouring rural areas in
2014 revealed the presence of C. pneumoniae in 31.4% of febrile
children with respiratory infections using diagnostic real-time
PCR [12]. Moreover, among 100 South African children with
lower respiratory tract symptoms, 6% were reported to have
C. trachomatis infections [13].
The aim of this study was to search for Chlamydiaceae and
Chlamydia-related emerging pathogens among hospitalized febrile
children with respiratory tract symptoms and age-matched fever-
free controls from Ghana in West Africa.
Materials and methods
From November 2013 to September 2015, oropharyngeal swabs
(ﬂocked swabs; Copan Industries, Brescia, Italy) were collected
from 572 children older than 1 month and younger than 15 years
with a tympanic temperature of38°C admitted to the paediatric
ward of Agogo Presbyterian Hospital, a district hospital with 250
beds situated in the Asante Akim North municipality, Ghana. The
admitted children presented either symptoms of the lower (i.e.
cough, intercostal retractions, chest indrawings or nasal ﬂaring;
n = 522) or upper (i.e. blocked nose, coryza; n = 50) respiratory
tract.
Additionally, oropharyngeal swabs from 560 fever-free
asymptomatic children younger than 15 years of age with a tem-
perature of <37.5°C without signs of a respiratory tract infection
were recruited at vaccination clinics surrounding Agogo Presby-
terian Hospital from September 2014 to September 2015. Brieﬂy,
DNA was extracted in Ghana using the Stratec Molecular RTP
Pathogen Kit (Stratec Biomedical, Birkenfeld, Germany) and
frozen at −80°C. We then performed a broad range pan-Chla-
mydiales 16S rRNA real-time PCR, as described elsewhere [3]. As
a positive control, we used plasmid pCR2.1-TOPO (Thermo
Scientiﬁc Fisher, Rheinach, Switzerland) which contained a
portion of the 16S rRNA gene targeted by the pan-Chlamydiales
16S rRNA real-time PCR and genomic DNA from C. trachomatis
D/UW-3/Cx. Moreover, internal ampliﬁcation (RT-IPCY-B02;
Eurogentec, Seraing, Belgium), extraction and no template con-
trols were performed. Samples with a cycle threshold of 37
were considered positive.
After transport on dry ice to Europe, the 16S rRNA pan-
Chlamydiales real-time PCR results were conﬁrmed, and all
samples with a cycle threshold of 35 were subjected to a
complementary Chlamydiaceae-speciﬁc 23S rRNA real-time PCR
[14]. The Chlamydiaceae-speciﬁc real-time PCR included internal
ampliﬁcation (using primers EGFP-1-F and EGFP-10-R [15]),
positive (using genomic DNA from Chlamydia abortus) and no
template controls. Additionally, samples with a cycle threshold of
35 in the 16S rRNA pan-Chlamydiales real-time PCR were
analysed by sequencing the 16S rRNA amplicon. Practically, the
best BLAST hit (http://blast.ncbi.nlm.nih.gov/Blast.cgi) of the ob-
tained sequencewith a 16S rRNA sequence from a bacterial strain
that has been previously assigned taxonomically to a given species-
level lineage was considered the ﬁrst known organism in the
National Center for Biotechnology Information (NCBI) database,
and the percentage of similarity with that hit was used to perform
the taxonomic assignment, as previously described [3,16–18].
Cutoffs of 80% [19], 92.5% [20], 95% [21] and 97% [22]
sequence identity of the amplicon were used to assign the or-
der, family, genus and species level, respectively. Short sequences
(in the range of 97–108 bp) were assigned at the genus level if
sequence identities of95% were found, and at the family level if
sequence identities of 92.5% and <95% were found.
In the statistical analysis, categorical variableswere described as
frequencies and percentages. Continuous variables were
described using medians and their corresponding interquartile
ranges (IQRs). To display age effects, four age categories (0, 1, 2–4
and >4 years) were established. The chi-square test was used to
compare means, with p <0.05 being considered statistically sig-
niﬁcant. All data analyses were performed by Stata 14 (StataCorp,
College Station, TX, USA). The Committee on Human Research,
Publications and Ethics, School of Medical Sciences, Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana,
and the Ethikkommission der Ärztekammer Hamburg, Hamburg,
Germany, provided ethical approval for this study. All participants
were informed about the study’s purpose and procedures.
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Written informed consent was obtained from parents or guard-
ians on behalf of the study children before study enrolment.
Results
Wescreened oropharyngeal swabs from 572 febrile childrenwith
respiratory tract symptoms and from an age-matched symptom-
less control group of 560 afebrile children from Ghana. Age was
distributed similarly between cases (median, 24 months; IQR,
12–44 months) and controls (median, 23 months; IQR, 13–47
months) (Table 1). Girls were slightly underrepresented among
cases (46.0%) and overrepresented among controls (51.8%). Us-
ing a pan-Chlamydiales broad-range real-time PCR [3], we found
chlamydial DNA in 11 (1.9%, mean cycle threshold 34.1±2.7)
febrile children with respiratory tract symptoms and in 24 (4.3%,
mean cycle threshold 35.3±1.6) asymptomatic children (total
n = 35), with the microorganism being signiﬁcantly more frequent
among the control group (p 0.03). With a median age of 23
months (IQR, 16–36) Chlamydiales-positive children did not
exhibit any different age distribution among groups. No temporal
patterns or seasonalities were observed.
Among the 35 Chlamydiales-positive samples, sequencing of the
16S rRNA amplicons and/or real-time PCR targeting the 23S
rRNA gene allowed us to classify 15 chlamydiae-positive samples
to the family (n= 5), genus (n= 2) or species (n= 8) level (Table 2).
The phylogenetically characterized samples (n = 15) originated
from six febrile (three boys, three girls) and nine healthy children
(ﬁve boys, four girls). In four febrile children aged 1 to 4 years,
partial 16S rRNA sequences (range, 135–206 bp) showed 100%
sequence identity to C. pneumoniae. In one 3-year-old boy, the
retrieved sequence was too short (108 bp) to determine the
chlamydial species but could be assigned to the genus Chlamydia.A
novel Chlamydia-related species belonging to an as-yet unclassiﬁed
family was detected in a sample of a symptomatic 1-year-old girl.
All six children hadbody temperatures between 38.3°C and 40°C,
and had a cough (n = 5) and/or a runny or blocked nose (n = 4).
Children in the control group with positive PCR results (n = 9)
were between 11 months and 10 years old, and they were clini-
cally healthy, with body temperatures ranging from 36.2°C to
37.4°C. Sequencing revealed partial 16S rRNA sequences with
100% sequence identity with C. pneumoniae (n = 3) and
C. trachomatis (n = 1). In the other ﬁve cases, chlamydial deter-
mination at the species levelwas not possible, but sequences could
be grouped into the genus Protochlamydia (n = 1), the family Par-
achlamydiaceae (n = 1) or Chlamydiaceae (n = 2), or into a new
family of the order Chlamydiales (n = 1).
Discussion
Epidemiologic studies on the causative role of pathogens in
human diseases are frequently limited by the lack of a respective
equally sized, age-matched control group, in particular when
evaluating emerging pathogens as an aetiologic agent. We
conducted what is to our knowledge the largest case–control
study on the prevalence of pathogenic Chlamydiaceae and
emerging pathogens among Chlamydia-related bacteria in chil-
dren with febrile respiratory tract infections. Compared to a
previous study from Switzerland including children with
(n = 265) and without pneumonia (n = 157) [3], our work
revealed an almost fourfold lower level of exposure to Chla-
mydiales among Ghanaian children (11.4% in Switzerland vs.
3.1% in Ghana). In contrast to the Swiss study, where Chlamy-
diaceae were almost exclusively detected in ill children, we
found Chlamydiaceae to be abundant among Ghanaian children
both with and without respiratory tract infection. The most
prevalent species identiﬁed in this study was C. pneumoniae.
This respiratory tract pathogen was found in four of six and
three of nine phylogenetically characterized samples from case
and control patients, respectively.
C. pneumoniae has been described to cause asymptomatic in-
fections in clinically healthy patients [23,24], and our results
indicate the presence of such subclinical infections or coloniza-
tion with C. pneumoniae in the control group. The children
included in our study are, at least in the neighbouring rural area of
Agogo, in close contact with poultry and other livestock that are
implicated in the zoonotic transmission of C. psittaci to humans.
Nevertheless, we did not detect C. psittaci but found DNA of a
member of a new chlamydial family sharing 90.2% sequence
identitywith the 16S rRNA sequence of C. pecorum, awell-known
animal pathogen that can be zoonotically transmitted from
TABLE 1. Demographic characteristics of study participants
Characteristic Total (n [ 1132) Symptomatic cases (n [ 572) Controls (n [ 560)
Sex (% female) 553 (48.9) 263 (46.0) 290 (51.8)
Age (months), median (interquartile range) 23 (12–47) 24 (12–44) 23 (13–47)
Age category, n (%)
0 years 272 (24.0) 133 (23.3) 139 (24.8)
1 year 348 (30.7) 141 (24.7) 207 (37.0)
2–4 years 253 (22.4) 176 (30.8) 77 (13.5)
>4 years 259 (22.9) 122 (21.3) 137 (24.5)
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livestock to humans [25]; this new lineage, however, is clearly
distinct from C. pecorum. In a healthy 11-month-old boy, we
detected C. trachomatis, indicating an asymptomatic infection
transmitted from a genitally infected mother during vaginal birth.
A recent Swiss report revealed a lack of Chlamydia-related
bacteria in adult patients with community-acquired pneumonia
[8]. In line with this report, we found only one novel Chlamydia-
related species in a symptomatic child: a febrile 1-year-old girl
with a body temperature of 40°C with upper and lower res-
piratory tract symptoms. The chlamydial species belonged to a
novel family that shared 91.3% sequence identity in the 16S
rRNA gene with Candidatus Syngnamydia venezia, a species
related to Simkania [26]. In our study, we did not detect any
Simkania negevensis DNA. This is in accordance with studies
that did not observe an association between the presence of
S. negevensis and respiratory tract infections in children [3,27]
and that did not conﬁrm the earlier work of Kahane et al.
[28]. In contrast to Swiss children, who were found to be
commonly exposed to Parachlamydiaceae [3], we found mem-
bers of this Chlamydia-related family in only two healthy
Ghanaian children, although none in the symptomatic group. In
summary, our results indicate that both Chlamydiaceae and
Chlamydia-related bacteria do not appear to be associated
with signiﬁcant pathogenicity in the Ghanaian children we
investigated.
This study provides novel insight into the prevalence of
Chlamydiales in children from West Africa. Moreover, we have
gained a broader view of the spectrum of Chlamydiales in res-
piratory tract infections as well as in healthy children. Our
ﬁndings of two new families further corroborate that the di-
versity of species belonging to the Chlamydiales order is still not
fully established. Further research is needed to precisely locate
the role of Chlamydiaceae and particularly of Chlamydia-related
bacteria as aetiologic agents in respiratory tract infections.
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TABLE 2. Classiﬁcation of 15 samples positive for Chlamydiaceae and Chlamydia-related bacteria in Ghanaian children
Child no. Age Sex
Temperature
(°C) Symptoms
23S
rRNA CT CT
16S rRNA
Sequence identity with ﬁrst
known organism in NCBI
database (accession no.)
Sequence
length
(bp) Classiﬁcation
Febrile with respiratory tract symptoms
1 2 years M 38.3 LRTS (cough), URTS (blocked
nose)
32.1 33.2 100% C. pneumoniae IOL207
(Z49874)
206 C. pneumoniae
2 1 year F 39.4 LRTS (cough), URTS (runny
nose)
ND 34.9 100% C. pneumoniae IOL207
(Z49874)
206 C. pneumoniae
3 1 year F 39.4 LRTS (X-ray: perihilar
inﬁltrates), no URTS
33.6 34.4 100% C. pneumoniae
(LN849050)
135 C. pneumoniae
4 1 year F 40 LRTS (cough, nose ﬂaring),
URTS (blocked nose, runny
nose)
ND 34.5 91.3% Candidatus, Syngnamydia
venezia strain Pi3-2, partial
sequence (KC182514)
207 New family
5 4 years M 38.7 LRTS (cough), no URTS 32.8 32.2 100% C. pneumoniae
(LN849050)
205 C. pneumoniae
6 3 years M 39.6 No LRTS, URTS (runny nose) ND 26.9 100% C. pneumoniae IOL207
(Z49874)
108 Chlamydia
Fever-free control without respiratory tract symptoms
7 1 year F 36.9 NA ND 34.4 95.9% Protochlamydia
naegleriophila genome
assembly PNK1,
chromosome: cPNK
(LN879502)
97 Protochlamydia
8 1 year F 36.5 NA ND 34.2 95.2% Protochlamydia
naegleriophila strain KNic,
partial sequence
(NR_115817)a
146 Parachlamydiaceae
9 10 years M 37.3 NA 31.5 31.2 100% C. pneumoniae IOL207
(Z49874)
176 C. pneumoniae
10 9 years M 37 NA 37.2 34.2 90.2% C. pecorum (NR_121750) 205 New family
11 11 months M 37.4 NA 34.6 34.2 100% C. trachomatis (HE605380) 176 C. trachomatis
12 1 year F 36.7 NA 22.1 31.5 100% C. pneumoniae IOL207
(Z49874)
205 C. pneumoniae
13 1 year F 36.6 NA 23.3 32.8 100% C. pneumoniae IOL207
(Z49874)
204 C. pneumoniae
14 7 years M 36.2 NA 34.4 35.3 ND NA Chlamydiaceae
15 1 year M 36.9 NA 34.4 35.2 ND NA Chlamydiaceae
Analysis of children for Chlamydiaceae and Chlamydia-related bacteria using real-time PCR and sequencing, Ghana. Oropharyngeal samples with cycle threshold 35 in 16S rRNA
pan-Chlamydiales real-time PCR were further analysed by 23S rRNA Chlamydiaceae-speciﬁc real-time PCR and by sequencing 16S rRNA amplicon.
bp, base pairs (if not self-explaining); CT, threshold cycle; F, female; LRTS, lower respiratory tract symptoms; M, male; NA, not applicable; NCBI, National Center for Biotechnology
Information; ND, not done; URTS, upper respiratory tract symptoms.
aWe obtained two different sequences with forward and reverse primers, both exhibiting 95.2% sequence identity with different BLAST hits; BLAST hit obtained with reverse primer
shown. With forward primer, we also obtained sequence assigned to Parachlamydiaceae family, but best-known hit was Neochlamydia sp. (LN995859).
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